Leukemia

CLL 2nd+ line and Extension
Gilead GS-US-312-0116 &  0117 (USOR 11235 & 12016) 
Phase III
Rituxan +/- GS-1101; GS-1101 in 2 strengths
Relapsed/Refractory CLL < 24 months after a CD20+ Ab response or >2 cytotoxic chemo regimens.

 

CML 1st line observational
BMS CA 180-330                        (USOR 11079) 
Phase Not Available
Studying interventions with TKIs: Imatinib, Dasatinib, or Nilotinib.
Started 1st TKI after 10/1/2010

PHONE (805) 485-8709

FAX (805-485-5521

  • LinkedIn Social Icon
  • Yelp Social Icon
  • Facebook Social Icon

Oxnard Office: 1700 North Rose Ave Suite 320, Oxnard, CA  93030

Ventura Office: 2900 Loma Vista Road Suite 200, Ventura, CA  93003
Camarillo Office: 500 Paseo Camarillo Suite 106, Camarillo, CA 93010

Copyright ©2002-2020

Ventura County Hematology Oncology Specialists